Role of home blood pressure monitoring in resistant hypertension
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hyue Mee | - |
dc.contributor.author | Shin, Jinho | - |
dc.date.accessioned | 2023-02-21T05:35:06Z | - |
dc.date.available | 2023-02-21T05:35:06Z | - |
dc.date.created | 2023-02-08 | - |
dc.date.issued | 2023-01 | - |
dc.identifier.issn | 2635-6325 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/182358 | - |
dc.description.abstract | The definition of resistant hypertension (RHT) has been updated to include failure to achieve target blood pressure (BP) despite treatment with ≥3 antihypertensive drugs, including diuretics, renin-angiotensin system blockers, and calcium channel blockers, prescribed at the maximum or maximally tolerated doses, or as success in achieving the target blood pressure but requiring ≥4 drugs. RHT is a major clinical problem, as it is associated with higher mortality and morbidity than non-RHT. Therefore, it is crucial to accurately identify RHT patients to effectively manage their disease. Out-of-clinic BP measurement, including home BP monitoring and ambulatory BP monitoring is gaining prominence for the diagnosis and management of RHT. Home BP monitoring is advantageous as it is feasibly repetitive, inexpensive, widely available, and because of its reproducibility over long periods. In addition, home BP monitoring has crucial advantage of allowing safe titration for the maximum or maximally tolerable dose, and for self-monitoring, thereby improving clinical inertia and nonadherence, and allowing true RHT to be more accurately identified. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | BioMed Central Ltd | - |
dc.title | Role of home blood pressure monitoring in resistant hypertension | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Shin, Jinho | - |
dc.identifier.doi | 10.1186/s40885-022-00226-1 | - |
dc.identifier.scopusid | 2-s2.0-85146356508 | - |
dc.identifier.wosid | 000912851400001 | - |
dc.identifier.bibliographicCitation | Clinical Hypertension, v.29, no.1, pp.1 - 7 | - |
dc.relation.isPartOf | Clinical Hypertension | - |
dc.citation.title | Clinical Hypertension | - |
dc.citation.volume | 29 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 7 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002923949 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Peripheral Vascular Disease | - |
dc.subject.keywordPlus | UNITED-STATES | - |
dc.subject.keywordPlus | NONADHERENCE | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | METAANALYSI | - |
dc.subject.keywordPlus | SPROGNOSIS | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordPlus | APPARENT | - |
dc.subject.keywordPlus | SOCIETY | - |
dc.subject.keywordAuthor | Adherence | - |
dc.subject.keywordAuthor | Ambulatory blood pressure monitoring | - |
dc.subject.keywordAuthor | Home blood pressure monitoring | - |
dc.subject.keywordAuthor | Pseudoresistance | - |
dc.subject.keywordAuthor | Resistant hypertension | - |
dc.subject.keywordAuthor | Self-monitoring | - |
dc.subject.keywordAuthor | White-coat effect | - |
dc.identifier.url | https://clinicalhypertension.biomedcentral.com/articles/10.1186/s40885-022-00226-1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.